Skip to main content
. Author manuscript; available in PMC: 2024 Mar 13.
Published in final edited form as: Lancet Public Health. 2022 Feb 10;7(3):e210–e218. doi: 10.1016/S2468-2667(21)00304-2

Figure 3: Model-derived expected probability of naloxone use in the event of a witnessed opioid overdose and deaths averted for 0 to 1000 distributed naloxone two-dose kits (through community-based access points) per 100 000 total population per year for three modelled states within each of the four dominant opioid epidemic types.

Figure 3:

Datapoints are observed volumes of distributions of naloxone kits in 2017, with lines showing estimated probabilities of naloxone use and deaths due to opioid overdose averted. Shaded areas show 95% credible intervals. State abbreviations are shown in place of full names.